I guess the negative part is that the people developing the vaccine can be a little bit less conservative with their design, since they have no incentive to be extra careful to avoid expensive lawsuits.
...and I believe that's part of the point of the Act itself: free up reluctances from those in better position to be able to come up with a solution. This is the same reason why everywhere in the world the vaccines have been approved for use under Emergency Use rules.